Elekta AB (publ) (OTCMKTS:EKTAY) Sees Large Decrease in Short Interest

Elekta AB (publ) (OTCMKTS:EKTAY) was the recipient of a large decline in short interest in February. As of February 28th, there was short interest totalling 100 shares, a decline of 66.7% from the February 13th total of 300 shares. Based on an average daily volume of 17,600 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.

Elekta AB (publ) Price Performance

OTCMKTS:EKTAY traded up $0.25 during midday trading on Friday, hitting $5.60. The company had a trading volume of 16,942 shares, compared to its average volume of 9,312. Elekta AB has a 52-week low of $5.25 and a 52-week high of $8.24. The stock’s fifty day moving average price is $5.75 and its 200-day moving average price is $6.01. The company has a market capitalization of $2.15 billion, a PE ratio of 22.39 and a beta of 1.25. The company has a quick ratio of 0.81, a current ratio of 1.05 and a debt-to-equity ratio of 0.60.

Elekta AB (publ) (OTCMKTS:EKTAY) last announced its earnings results on Friday, February 21st. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.01). Elekta AB (publ) had a return on equity of 11.07% and a net margin of 5.65%. The company had revenue of $416.86 million during the quarter, compared to analysts’ expectations of $435.89 million. As a group, research analysts expect that Elekta AB will post 0.36 earnings per share for the current year.

Elekta AB (publ) Cuts Dividend

The business also recently announced a dividend, which will be paid on Thursday, March 27th. Investors of record on Friday, March 7th will be given a $0.1072 dividend. The ex-dividend date of this dividend is Friday, March 7th. Elekta AB (publ)’s dividend payout ratio (DPR) is presently 40.00%.

Wall Street Analysts Forecast Growth

Separately, Sanford C. Bernstein upgraded shares of Elekta AB (publ) from a “strong sell” rating to a “hold” rating in a research report on Wednesday, January 29th.

Elekta AB (publ) Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.